|
ABSL |
animal biosafety level |
|
ACE-2 receptor |
Angiotensin-converting enzyme 2 |
|
APHIS |
Animal and Plant Health Inspection Service |
|
BARDA |
Biomedical Advanced Research and Development Authority |
|
BMBL |
Biosafety in Microbiological and Biomedical Laboratories |
|
BSAT |
Biological Select Agents and Toxins |
|
BSL |
biosafety level |
|
CDC |
U.S. Centers for Disease Control and Prevention |
|
cDNA |
complementary deoxyribonucleic acid |
|
CoV |
coronavirus |
|
CRISPR |
clustered regularly interspaced short palindromic repeats |
|
DNA |
deoxyribonucleic acid |
|
DURC |
dual use research of concern |
|
EID |
Emerging Infectious Diseases |
|
FBI |
Federal Bureau of Investigation |
|
GAO |
Government Accountability Office |
|
GOF |
gain-of-function |
|
HA |
hemagglutinins |
|
HAE |
human airway epithelial |
|
HEPA |
high-efficiency particulate arrestance |
|
HPAIV |
highly pathogenic avian influenza viruses |
|
IACUC |
Institutional Animal Care and Use Committees |
|
IBC |
Institutional Biosafety Committee |
|
IOM |
Institute of Medicine |
|
IRI |
Influenza Research Institute (at the University of Wisconsin-Madison) |
|
JCVI |
J. Craig Venter Institute |
|
LAI |
Laboratory Acquired Infection |
|
mAb |
monoclonal antibody |
|
MERS |
Middle East respiratory syndrome |
|
NA |
neuraminidase |
|
NAS |
National Academy of Sciences |
|
NIAID |
National Institute of Allergy and Infectious Diseases |
|
NIH |
National Institutes of Health |
|
NSABB |
National Science Advisory Board for Biosecurity |
|
NRC |
National Research Council |
|
PLoS |
Public Library of Science |
|
PPE |
personal protective equipment |
|
PPP |
potential pandemic pathogens |
|
RNA |
ribonucleic acid |
|
SARS |
severe acute respiratory syndrome |
|
SGVI |
Synthetic Genomics Vaccines |
|
SL-CoV |
SARS-like CoV |
|
S&T |
science and technology |
|
UPMC |
University of Pittsburgh Medical Center |
|
USDA |
U.S. Department of Agriculture |
|
USG |
U.S. Government |
|
USNRC |
U.S. Nuclear Regulatory Commission |
